Orvida Pharma is a clinical-stage company developing first-in-class, disease-modifying therapies for rare and underserved severe skin diseases
Orvida Pharma is a clinical-stage company developing first-in-class, disease-modifying therapies for rare and underserved severe skin diseases. By targeting the TRPV3 pathway, Orvida is advancing a systemic oral treatment across multiple orphan indications, including Olmsted syndrome, keratodermas and Ichthyosis.